BioCentury
ARTICLE | Company News

CSL to acquire Zenyth

July 18, 2006 12:54 AM UTC

CSL (ASX:CSL) will acquire Zenyth (ASX:ZTL) for A$0.82 per share, or about A$102.7 million (US$77.3 million), in cash. The price is a 52% premium to ZTL's close of A$0.54 on July 14, the last trading day before the deal was announced. Also, for every six ZTL shares held, ZTL will give its shareholders one share in a company that was spun out of ZTL last year, which represents an additional A$0.04 in value per ZTL share, or about A$5 million (US$3.8 million). ...